ArticleInternational journal of biological sciences2021

Inflammation characteristics and anti-inflammation treatment with tocilizumab of severe/critical COVID-19 patients: A retrospective cohort study.

Qin Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.